M9140

· EMD Serono Research & Development Institute, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for M9140, covering 2026-04-23 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor) [Phase 1, Phase 2]